GLP-1 Market
LLY $1123.00 ▼ -0.1% NVO $44.01 ▼ -1.2% PFE $27.65 ▼ -0.5% VKTX $32.13 ▼ -1.7% KLRA $14.91 ▲ +0.5% GPCR $39.55 ▼ -4.1% RHHBY $53.19 ▼ -0.4% HIMS $27.44 ▼ -1.6% WW $14.78 ▼ -1.1%
Delayed · As of 9:20 AM

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Insulin Aspart

Company
Novo Nordisk A/S
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
6 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

6 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Find a Clinical Trial Near Me

See recruiting studies for Insulin Aspart and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT03463564

    Insulin Pump vs Multiple Daily Injections of Insulin and Glyco-metabolic Control in Type 1 Diabetic Patients

    Not yet reported University of Campania Luigi Vanvitelli 150 participants Est. completion 2026-12 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Recruiting NCT NCT03987308

    Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM Patients

    Not yet reported Beijing Hospital 115 participants Est. completion 2025-12 16 sites
    Type 2 diabetes Other conditions: Type 2 Diabetic Patients
    View official trial listing →
  • Recruiting NCT NCT05946785

    Oxidative Stress in Microvascular Dysfunction Following Gestational Diabetes

    Not yet reported Anna Stanhewicz, PhD 28 participants Est. completion 2027-06-01 1 site Stand-alone
    Other conditions: Gestational Diabetes, Vascular Endothelial Function
    View official trial listing →
  • Recruiting NCT NCT06445946

    DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

    Not yet reported Ohio State University 1572 participants Est. completion 2030-12 24 sites
    Other conditions: Gestational Diabetes Mellitus, Pregnancy, High Risk
    View official trial listing →
  • Recruiting NCT NCT06547619

    Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM

    Not yet reported Anna Stanhewicz, PhD 40 participants Est. completion 2027-05 1 site Stand-alone
    Other conditions: Gestational Diabetes, Endothelial Dysfunction, Physical Inactivity
    View official trial listing →
  • Recruiting NCT NCT06739473

    Total-body Glucose Utilization in Obesity

    Not yet reported Turku University Hospital 60 participants Est. completion 2024-12 1 site
    Other conditions: Obesity and Overweight
    View official trial listing →
  • Completed NCT NCT00046150

    12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes.

    Not yet reported Sanofi 59 participants Est. completion 2002-12 3 sites
    Other conditions: Diabetes, Type I
    View official trial listing →
  • Completed NCT NCT00065130

    Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes

    Not yet reported Novo Nordisk A/S 27 participants Est. completion 2003-12 1 site
    Other conditions: Diabetes, Gestational Diabetes
    View official trial listing →
  • Completed NCT NCT00071448

    Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population

    Not yet reported Novo Nordisk A/S 378 participants Est. completion 2004-06 76 sites
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00095082

    Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 447 participants Est. completion 2005-12 81 sites
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00095446

    NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 513 participants Est. completion 2005-03 1 site
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00097071

    Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents

    Not yet reported Novo Nordisk A/S 299 participants Est. completion 2006-05 52 sites
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00097084

    Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 324 participants Est. completion 2005-12 60 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00097877

    Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 293 participants Est. completion 2006-11 73 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00101751

    INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study

    Not yet reported Novo Nordisk A/S 4877 participants Est. completion 2006-06 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00115973

    A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump

    Not yet reported Novo Nordisk A/S 71 participants Est. completion 2006-01 6 sites
    Type 2 diabetes Other conditions: Diabetes, Delivery Systems
    View official trial listing →
  • Completed NCT NCT00117780

    Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 520 participants Est. completion 2006-10 3 sites
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00121966

    South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2 Diabetes Mellitus

    Not yet reported Odense University Hospital 400 participants Est. completion 2007-07 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00135941

    Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2)

    Not yet reported Sanofi 582 participants Est. completion 2007-09 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00151697

    LANN-study: Lantus, Amaryl, Novorapid, Novomix Study

    Not yet reported Rijnstate Hospital 150 participants 1 site
    Other conditions: Diabetes Mellitus Type II
    View official trial listing →
  • Completed NCT NCT00174668

    Insulin Glulisine in Diabetes Mellitus, Type 2

    Not yet reported Sanofi 311 participants 15 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00184574

    Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 603 participants Est. completion 2006-03 108 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00184613

    Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 22 participants Est. completion 2006-01 1 site
    Type 2 diabetes Other conditions: Diabetes, Delivery Systems
    View official trial listing →
  • Completed NCT NCT00184626

    Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes.

    Not yet reported Novo Nordisk A/S 97 participants Est. completion 2005-10-24 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00184665

    Comparison of Insulin Detemir With NPH Insulin in Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 501 participants Est. completion 2006-09 29 sites
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Terminated NCT NCT00206206

    Evaluation of an ICU Hyperglycemia Protocol Using Insulin Aspart

    Not yet reported Atlantic Health System 235 participants 1 site
    Other conditions: Hyperglycemia
    View official trial listing →
  • Terminated NCT NCT00228865

    Clinical Effects of Pulsatile Insulin Delivery on Cognitive Function- Phase 1

    Not yet reported, Not yet reported Florida Atlantic University 75 participants Est. completion 2009-08 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT00228878

    Effect Pulsatile IV Insulin Therapy on the Quality of Life in Patients With Types 1 and 2 Diabetes

    Not yet reported, Not yet reported Florida Atlantic University 152 participants Est. completion 2009-08 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT00228891

    Effects of Pulsatile Insulin Delivery on Diabetic Neuropathy in Patients With Types 1 and 2 Diabetes Mellitus

    Not yet reported, Not yet reported Florida Atlantic University 152 participants Est. completion 2009-08 1 site
    Other conditions: Diabetes Mellitus, With Complications
    View official trial listing →
  • Withdrawn NCT NCT00228904

    Effects of Pulsatile Intravenous Insulin Delivery on Diabetic Neuropathy in pATIENTS (Pts) With Type 1 and Type 2 Diabetes

    Not yet reported, Not yet reported Florida Atlantic University Est. completion 2011-10 1 site
    Other conditions: Diabetic Neuropathy
    View official trial listing →
  • Completed NCT NCT00232583

    Preservation of Beta-cell Function in Type 2 Diabetes Mellitus

    Not yet reported University of Texas Southwestern Medical Center 58 participants Est. completion 2011-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT00254085

    Substitution of First Phase Insulin Response in Patient With Type 2 Diabetes.

    Not yet reported University Hospital, Gentofte, Copenhagen 20 participants Est. completion 2006-03 1 site
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT00267683

    Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 9 participants Est. completion 2006-04
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00274274

    Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 373 participants Est. completion 2006-11 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00282451

    Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin Aspart, With or Without Metformin in Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 79 participants Est. completion 2006-08 4 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00283218

    A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphasic Insulin Aspart 30, 50 and 70.

    Not yet reported University of Aarhus 24 participants Est. completion 2006-08 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Terminated NCT NCT00287651

    Effects of Pulsatile IV Insulin Delivery on Diabetic Retinopathy in Patients With Types 1 and 2 Diabetes Mellitus

    Not yet reported, Not yet reported Florida Atlantic University 150 participants Est. completion 2009-08 1 site
    Other conditions: Diabetes Mellitus, With Complications
    View official trial listing →
  • Completed NCT NCT00309244

    Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up

    Not yet reported Mannkind Corporation 677 participants Est. completion 2008-09 151 sites
    Other conditions: Diabetes Type 2
    View official trial listing →
  • Completed NCT NCT00312104

    Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 325 participants Est. completion 2003-03 46 sites
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00312156

    Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 347 participants Est. completion 2003-08 42 sites
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00318786

    Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day BIAsp-30 in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 289 participants Est. completion 2007-06 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Terminated NCT NCT00322257

    Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 596 participants Est. completion 2008-04-02 96 sites
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00346996

    Insulin Analogues and Severe Hypoglycaemia

    Not yet reported Lise Tarnow 179 participants Est. completion 2012-08 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00353990

    Bioavailability of Insulin Administered in Duodenum

    Not yet reported, Not yet reported University of Aarhus 12 participants Est. completion 2006-12 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT00361907

    Effect of Pulsatile IV Insulin on Circulating Risk Markers of Vascular and Metabolic Complications in Pts With Diabetes

    Not yet reported, Not yet reported Florida Atlantic University 105 participants Est. completion 2009-08 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00365170

    Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 419 participants Est. completion 2005-04 95 sites
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00384085

    Insulin Glargine "All to Target" Trial

    Not yet reported Sanofi 588 participants Est. completion 2010-03 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00385242

    PET and Recovery Following Revascularization (PARR 2)

    Not yet reported Ottawa Heart Institute Research Corporation 430 participants Est. completion 2011-06 1 site
    Cardiovascular disease Other conditions: Ventricular Dysfunction, Left
    View official trial listing →
  • Completed NCT NCT00410033

    Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin

    Not yet reported Novo Nordisk A/S 74 participants Est. completion 2006-05 1 site
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00417989

    Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy

    Not yet reported Medtronic MiniMed, Inc. 485 participants Est. completion 2010-06 30 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Terminated NCT NCT00428207

    Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy

    Not yet reported Joslin Diabetes Center 4 participants Est. completion 2008-08 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00434954

    Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes

    Not yet reported AstraZeneca 494 participants Est. completion 2009-06 39 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00435019

    Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 348 participants Est. completion 2008-09 43 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00442767

    Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus

    Not yet reported Montefiore Medical Center 8 participants Est. completion 2009-02 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00447382

    Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 330 participants Est. completion 2008-07 5 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00461331

    Comparison of Insulins Aspart and Lispro in Insulin Pumps

    Not yet reported Tulane University Health Sciences Center 20 participants Est. completion 2008-08 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00467649

    A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes

    Not yet reported AstraZeneca 112 participants Est. completion 2008-04 37 sites
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT00472953

    Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Novo Nordisk A/S 38 participants Est. completion 2008-03-05 27 sites
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1, Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT00494078

    Efficiency of Continuous Glucose Monitoring in Critically Ill Patients

    Not yet reported Medical University of Vienna 120 participants Est. completion 2008-08 1 site
    Other conditions: Critical Illness
    View official trial listing →
  • Completed NCT NCT00494988

    Self-control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin Aspart

    Not yet reported Novo Nordisk A/S 33 participants Est. completion 2006-04 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00497536

    Pharmacokinetics of IAsp Following CSII in Patients With T1DM

    Not yet reported University of Aarhus 12 participants Est. completion 2008-07 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Withdrawn NCT NCT00505882

    Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes

    Not yet reported University of Texas Southwestern Medical Center Est. completion 2008-12 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Terminated NCT NCT00509925

    Effect of Insulin Detemir on Use of Energy in Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 23 participants Est. completion 2008-07 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00513643

    Metabolic Effect of Insulin Aspart and Human Insulin in Different Doses

    Not yet reported Profil Institut für Stoffwechselforschung GmbH 16 participants Est. completion 2002-06 1 site Stand-alone
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT00523042

    Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma

    Not yet reported Novo Nordisk A/S 10 participants Est. completion 2008-02-28 32 sites
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1, Asthma
    View official trial listing →
  • Completed NCT NCT00537303

    Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 296 participants Est. completion 2009-03 69 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00539396

    A 3 Month, Randomized, Open Label, Multi-center Study of Technosphere/Insulin Compared to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Receiving Insulin Glargine

    Not yet reported Mannkind Corporation 110 participants Est. completion 2005-12
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Withdrawn NCT NCT00539435

    Effects of Pulsatile Intravenous Insulin Therapy on Cardiac Disease in Patients With Diabetes

    Not yet reported Florida Atlantic University Est. completion 2012-09 1 site
    Other conditions: Diabetes Mellitus, With Complications
    View official trial listing →
  • Completed NCT NCT00542620

    Comparison of Insulin Detemir and Insulin Aspart in 2 Separate Injections Twice Daily to Extemporaneous Mixing Injection Regimen Twice Daily - The Paediatric Mixing Trial

    Not yet reported Novo Nordisk A/S 25 participants Est. completion 2009-03 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Terminated NCT NCT00564018

    Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH

    Not yet reported University of Texas Southwestern Medical Center 33 participants Est. completion 2011-04 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00564395

    Detemir: Role in Type 1 Diabetes

    Not yet reported Montefiore Medical Center 18 participants Est. completion 2010-05 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00564668

    Comparison of Biphasic Insulin Aspart Produced by the NN2000 Process to Current Process to in Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 126 participants Est. completion 2005-04-12 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00571935

    Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 61 participants Est. completion 2004-10 5 sites
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00574405

    Preservation of Pancreatic Beta Cell Function Through Insulin Pump Therapy

    Not yet reported Arkansas Children's Hospital Research Institute 24 participants Est. completion 2011-03 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00575172

    Nippon Ultra-Rapid Insulin and Diabetic Complication Evaluation-Study (NICE-Study)

    Osaka Saiseikai Nakatsu Hospital 346 participants Est. completion 2007-12 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00581867

    Memory and Insulin in Early Alzheimer's Disease

    Not yet reported, Not yet reported Jeff Burns, MD 31 participants Est. completion 2012-05 1 site Stand-alone
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT00590226

    Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes

    Not yet reported Emory University 130 participants Est. completion 2008-04 2 sites
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT00591071

    Impact of 2 Blood Glucose Levels on Hospital Mortality in Patients Admitted in ICU

    Not yet reported Poissy-Saint Germain Hospital 440 participants Est. completion 2010-09 2 sites
    Other conditions: Hyperglycemia, Critically Ill Patients
    View official trial listing →
  • Completed NCT NCT00591227

    Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol.

    Not yet reported Rush University Medical Center 176 participants Est. completion 2009-07 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00593255

    Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 220 participants Est. completion 2005-04 5 sites
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00595374

    Efficacy and Safety of Insulin Detemir in Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 114 participants Est. completion 2004-10-07 18 sites
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00598793

    Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy

    Not yet reported Novo Nordisk A/S 242 participants Est. completion 2004-03 27 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00600366

    Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 71 participants Est. completion 2005-01 4 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00600626

    Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 394 participants Est. completion 2004-07 55 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00605111

    Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 193 participants Est. completion 2004-10 17 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00607087

    Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus

    Not yet reported Sanofi 289 participants Est. completion 2009-06 12 sites Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00612599

    Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 75 participants Est. completion 2004-06 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00613951

    Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 182 participants Est. completion 2008-08 31 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00614055

    Comparison of Two NN5401 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 178 participants Est. completion 2008-07 28 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00617565

    Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes

    Not yet reported Novo Nordisk A/S 219 participants Est. completion 2003-11-26 6 sites
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00619697

    Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 260 participants Est. completion 2005-03 54 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00623194

    Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689

    Not yet reported Novo Nordisk A/S 146 participants Est. completion 2009-09 32 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00624767

    A Study to Evaluate the Effect of Nasal Insulin on Postprandial Glycemic Control in Type 2 Diabetic Patients

    Not yet reported Nastech Pharmaceutical Company, Inc. 18 participants Est. completion 2008-05 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00625781

    Treatment of Impaired Glucose Tolerance in Pregnancy

    Not yet reported Region Örebro County 72 participants Est. completion 2013-12 1 site Stand-alone
    Prediabetes Other conditions: Fetal Macrosomia
    View official trial listing →
  • Completed NCT NCT00626080

    Insulin Detemir Action in Cerebro

    Not yet reported Amsterdam UMC, location VUmc 40 participants Est. completion 2011-12 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00627445

    Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 441 participants Est. completion 2009-01 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00645827

    Use of an Insulin Infusion Conversion Equation (IICE) to Control Blood Glucose in Hospitalized Patients

    Not yet reported Emory University 78 participants Est. completion 2009-03 1 site Stand-alone
    Other conditions: Glucose, Blood
    View official trial listing →
  • Completed NCT NCT00652288

    Evaluation of Pharmacokinetics and Pharmacodynamic Properties of Rapid-Acting Insulin Analogs

    Not yet reported Yale University 36 participants Est. completion 2011-09
    Other conditions: Diabetes Mellitus, Type I
    View official trial listing →
  • Completed NCT NCT00657319

    Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® Insulins

    Novo Nordisk A/S 3495 participants Est. completion 2008-04 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00657943

    The Copenhagen Insulin and Metformin Therapy Trial

    Not yet reported Steno Diabetes Center Copenhagen 415 participants Est. completion 2012-12 9 sites Stand-alone
    Type 2 diabetes Other conditions: Atherosclerosis, Arteriosclerosis
    View official trial listing →
  • Completed NCT NCT00659282

    Observational Study of Safety and Effectiveness of NovoMix® 30 for the Treatment of Diabetes

    Novo Nordisk A/S 57610 participants Est. completion 2008-11-15 11 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Withdrawn NCT NCT00663624

    Management of Hyperglycemia in the ER: A Randomized Clinical Trial of a Subcutaneous Insulin Aspart Protocol Coupled With Rapid Initiation of Basal Bolus Insulin Prior to Hospital Admission Versus Usual Care

    Not yet reported Emory University Stand-alone
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00665093

    Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes

    Novo Nordisk A/S 1569 participants Est. completion 2008-01 1 site
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00670722

    Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin

    Novo Nordisk A/S 6500 participants Est. completion 2009-12 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00671008

    Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes

    Novo Nordisk A/S 400 participants Est. completion 2008-09 1 site
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00675220

    Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™

    Novo Nordisk A/S 373 participants Est. completion 2007-12 1 site
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1, Delivery Systems
    View official trial listing →
  • Completed NCT NCT00675493

    Observational Study of Type 1 and Type 2 Diabetes Patients Having Switched From Human Premixes to NovoMix®30

    Novo Nordisk A/S 942 participants Est. completion 2009-01 1 site
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00676741

    Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin

    Novo Nordisk A/S 3809 participants Est. completion 2010-05 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00676819

    Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 19 participants Est. completion 2002-07-19 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00696163

    Observational Study to Assess the Quality of Life and Clinical Outcomes in Subjects Using NovoMix® 30 for the Treatment of Diabetes

    Novo Nordisk A/S 24975 participants Est. completion 2009-03 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00696995

    An Observational Study of Type 2 Diabetes in Patients Starting on NovoMix® 30 Treatment

    Novo Nordisk A/S 509 participants Est. completion 2008-09 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00698126

    Observational Study of Patients Using NovoRapid® or Soluble Human Insulin for Treatment of Type 2 Diabetes

    Novo Nordisk A/S 4099 participants Est. completion 2009-05 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00699179

    Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes

    Novo Nordisk A/S 2308 participants Est. completion 2009-09 1 site
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Terminated NCT NCT00700154

    Insulin Infusion Diabetes Ulcer

    Not yet reported Karolinska Institutet 40 participants Est. completion 2020-12-21 1 site
    Other conditions: Diabetes Mellitus, Insulin Resistance, Hyperglycemia, Surgery, Ulcers, Infection
    View official trial listing →
  • Withdrawn NCT NCT00700362

    Insulin Infusion and Infectious Diabetic Foot Ulcers (IIIFU)

    Karolinska Institutet Est. completion 2016-12 1 site
    Other conditions: Diabetes Mellitus, Insulin Resistance, Hyperglycemia, Infection
    View official trial listing →
  • Completed NCT NCT00700648

    An Observational Study to Assess Safety and Effectiveness of Intravenous NovoRapid® in Hospitalised Subjects

    Novo Nordisk A/S 3024 participants Est. completion 2008-09 1 site
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00704223

    Observational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 Diabetes

    Novo Nordisk A/S 619 participants Est. completion 2008-11 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00709683

    Observational Study to Evaluate the Safety of NovoMix® 30 FlexPen®

    Novo Nordisk A/S 216 participants Est. completion 2009-05 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00715663

    Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 Diabetes

    Novo Nordisk A/S 1584 participants Est. completion 2007-12 1 site
    Type 2 diabetes Other conditions: Diabetes, Delivery Systems
    View official trial listing →
  • Completed NCT NCT00715780

    Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic Agents

    Novo Nordisk A/S 1667 participants Est. completion 2009-07 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00725036

    Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 305 participants Est. completion 2004-12-14 18 sites
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00729898

    Observational Study to Observe the Safety of NovoMix® 30 Treatment in Patients With Type 2 Diabetes

    Novo Nordisk A/S 243 participants Est. completion 2010-09 2 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00737776

    Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of Diabetes

    Novo Nordisk A/S 1068 participants Est. completion 2010-01 1 site
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Status unknown NCT NCT00747409

    Insulin Effects on Metabolism and Cardiovascular Function in Type 2 Diabetes

    Not yet reported Munich Municipal Hospital 120 participants Est. completion 2009-06 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00755833

    Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 Months

    Novo Nordisk A/S 270 participants Est. completion 2010-04 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00764556

    Phase II Study of Safety and Feasibility of Intensive Blood Glucose Control With Insulin on Acute Medical Wards

    Not yet reported St George's, University of London 20 participants Est. completion 2009-05 1 site
    Other conditions: COPD, Hyperglycemia
    View official trial listing →
  • Completed NCT NCT00771693

    Effects of Insulin Treatment on Postprandial Platelet Activation in Patients With Non-insulin-dependent Diabetes Mellitus (NIDDM)

    Not yet reported Karolinska Institutet 18 participants Est. completion 2011-07 1 site
    Type 2 diabetes Other conditions: Postprandial Hyperglycemia
    View official trial listing →
  • Completed NCT NCT00773279

    Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics

    Not yet reported Novo Nordisk A/S 242 participants Est. completion 2009-06 65 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1, Delivery Systems
    View official trial listing →
  • Completed NCT NCT00775736

    Observational Study Evaluating the Safety of NovoMix® in Type 2 Diabetes Patients Previously Treated With a Human Premix Insulin

    Novo Nordisk A/S 611 participants Est. completion 2011-01 2 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00788840

    Detemir Energy Expenditure Study

    Not yet reported University of Surrey 30 participants Est. completion 2009-08 1 site
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00789711

    An Observational Study to Compare the Safety and Effectiveness of NovoMix® 30 and Levemir™ for the Treatment of Diabetes

    Novo Nordisk A/S 3131 participants Est. completion 2009-08 1 site
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00791895

    Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs

    Not yet reported Novo Nordisk A/S 102 participants Est. completion 2004-11-29 15 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00795600

    Comparison of the Change in Fat Distribution in Overweight and Obese Subjects With Type 2 Diabetes After Insulin Treatment

    Not yet reported Novo Nordisk A/S 60 participants Est. completion 2010-08 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00797823

    Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone

    Not yet reported Legacy Health System 14 participants Est. completion 2009-09 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00821795

    Veterans Inpatient Insulin Study and Transition to Outpatient Therapy

    Not yet reported Dennis G. Karounos, M.D. 120 participants Est. completion 2013-04-23 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00825253

    Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 in Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 2007-05 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00832182

    Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 75 participants Est. completion 2002-11-25 10 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00834262

    Observational Study on Safety and Efficacy of Biphasic Insulin Aspart in Type 2 Diabetes Patients

    Novo Nordisk A/S 339 participants Est. completion 2010-02 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00841087

    Comparison of NN1250 Versus Insulin Detemir, Both Combined With Insulin Aspart in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 65 participants Est. completion 2009-05 8 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00842361

    Comparison of NN5401 Versus Biphasic Insulin Aspart 30 on a Twice Daily Regimen in Subjects With Type 2 Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 66 participants Est. completion 2009-06 8 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Withdrawn NCT NCT00849316

    Safety and Efficacy Study of NovoRapid™ in Patients With Coexisting Diabetes and Kidney Disease

    Novo Nordisk A/S Est. completion 2009-11
    Type 2 diabetesChronic kidney disease Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Withdrawn NCT NCT00850161

    Intranasal Insulin and Its Effect on Postprandial Metabolism in Comparison to Subcutaneous Insulin

    Not yet reported CPEX Pharmaceuticals Inc. Est. completion 2010-09
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00869908

    Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication

    Novo Nordisk A/S 66726 participants Est. completion 2011-03 22 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00873639

    Observational Study of Type 1 Diabetics Switching From Human Insulins to Modern Insulin Analogues

    Novo Nordisk A/S 417 participants Est. completion 2009-11 1 site
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00888732

    A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, BIAsp70, BIAsp50 and Fast-acting Human Insulin

    Not yet reported University of Aarhus 24 participants Est. completion 2010-06 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Withdrawn NCT NCT00906529

    Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin

    Not yet reported University of Texas Southwestern Medical Center Est. completion 2011-03 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00910767

    Closing the Loop in Adults With Type 1 Diabetes

    Not yet reported University of Cambridge 12 participants Est. completion 2009-07 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00913497

    The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children

    Not yet reported Corewell Health West 16 participants Est. completion 2012-01 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00920725

    Subcutaneous Aspart Insulin to Treat Diabetic Ketoacidosis (DKA) and Beta-Hydroxybutyrate Testing in DKA

    Not yet reported Rush University Medical Center 50 participants Est. completion 2007-12 1 site
    Other conditions: Diabetic Ketoacidosis
    View official trial listing →
  • Terminated NCT NCT00967837

    Effects of Pulsatile Intravenous (IV) Insulin on Wound Healing in Diabetics

    Not yet reported, Not yet reported Florida Atlantic University 152 participants Est. completion 2012-09 1 site
    Other conditions: Wound Healing, Diabetes
    View official trial listing →
  • Completed NCT NCT00972283

    Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 1006 participants Est. completion 2010-10-28 136 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00978627

    Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 548 participants Est. completion 2010-05 81 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00982228

    Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 629 participants Est. completion 2010-11-08 91 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00992537

    Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Type 1 Diabetics

    Not yet reported Novo Nordisk A/S 27 participants Est. completion 2010-01 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00993096

    Investigation of the Response Relationship of NN5401 in Type 1 Diabetics

    Not yet reported Novo Nordisk A/S 33 participants Est. completion 2009-12 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00998335

    Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes

    Not yet reported University of Florida 30 participants Est. completion 2010-02 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01006889

    Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease

    Not yet reported University of Florida 24 participants Est. completion 2010-02 1 site Added to GLP-1
    MASLDType 2 diabetes
    View official trial listing →
  • Completed NCT NCT01009580

    Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 447 participants Est. completion 2010-08-23 53 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01022658

    INSUlin Regimens and VASCular Functions

    Not yet reported Assistance Publique - Hôpitaux de Paris 42 participants Est. completion 2011-07 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT01023165

    Effects of Intensive Bolus Intravenous Insulin Delivery on Metabolic Integrity in Type 1 and Type 2 Diabetes

    Not yet reported Global Infusion and Aspiration Systems, LLC 2000 participants Est. completion 2015-11 1 site
    Other conditions: Diabetes Mellitus, Metabolic Integrity
    View official trial listing →
  • Completed NCT NCT01028404

    A Two Part Trial Investigating NN1952 in Healthy Subjects and Subjects With Type 1 and Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 84 participants Est. completion 2010-06 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1, Healthy
    View official trial listing →
  • Terminated NCT NCT01029444

    Effects of Pulsed Intravenous (IV) Insulin on Brittle and Uncontrolled Diabetes

    Not yet reported Florida Atlantic University 300 participants Est. completion 2012-03 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Withdrawn NCT NCT01029639

    Effects of Pulsatile Intravenous Insulin Delivery on Hypoglycemic Unawareness

    Not yet reported, Not yet reported Florida Atlantic University Est. completion 2009-08 1 site
    Other conditions: Hypoglycemia
    View official trial listing →
  • Completed NCT NCT01039532

    Comparison of Thrice Daily Biphasic Human Insulin With Basal Bolus Regimen in Type 2 Diabetes Mellitus Patients

    Post Graduate Institute of Medical Education and Research, Chandigarh 50 participants Est. completion 2010-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01041755

    Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.

    Not yet reported Centro Regional para el Estudio de las Enfermedades Digestivas 30 participants Est. completion 2011-06 1 site
    Other conditions: Hepatic Encephalopathy
    View official trial listing →
  • Completed NCT NCT01045447

    Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 465 participants Est. completion 2010-10 65 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01051102

    Effect of NN5401 in Japanese Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 21 participants Est. completion 2010-04 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01053234

    Different Insulin Regimens and Postprandial Coagulation Activation

    Not yet reported Esbjerg Hospital - University Hospital of Southern Denmark 78 participants Est. completion 2007-05 1 site Stand-alone
    Type 2 diabetes Other conditions: Cardiovascular Risk, Hemostasis, Inflammation, Endothelial Function
    View official trial listing →
  • Completed NCT NCT01059812

    A Pan Asian Trial Comparing Efficacy and Safety of NN5401 and Biphasic Insulin Aspart 30 in Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 424 participants Est. completion 2010-12-23 46 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01068652

    Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs

    Not yet reported Novo Nordisk A/S 403 participants Est. completion 2012-05 19 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01074268

    Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 456 participants Est. completion 2010-12 69 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Terminated NCT NCT01079364

    Better Acceptance of Single Injection Apidra Added to Once Daily Lantus Versus Twice Daily Premixed Insulin in Real Life Use Setting

    Not yet reported Sanofi 52 participants Est. completion 2012-07 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT01088451

    Joint Application of Human Insulin and Rapid Insulin Analogue in Control of Postprandial Glycemia

    Not yet reported University Hospital Hradec Kralove 20 participants Est. completion 2010-09 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01101867

    Prandial Insulin Dosing in Hospitalized Patients

    Not yet reported Kathleen Dungan 126 participants Est. completion 2013-03 1 site
    Other conditions: Diabetes, Admitting Hospital, Non-critically Ill
    View official trial listing →
  • Completed NCT NCT01109316

    Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use

    Not yet reported Eli Lilly and Company 132 participants Est. completion 2011-08 11 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01121276

    A Trial Investigating NN1218 in Subjects With Type 1 and Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 82 participants Est. completion 2010-09 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01121835

    Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study

    Not yet reported Sanofi 934 participants Est. completion 2012-03 96 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01123980

    Comparison of the Blood Sugar Lowering Effect of Biphasic Insulin Aspart 30 and Insulin Glargine Both Combined With Metformin and Glimepiride in Chinese and Japanese Subjects With Type 2 Diabetes New to Insulin Treatment

    Not yet reported Novo Nordisk A/S 521 participants Est. completion 2011-06 34 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01134107

    Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use

    Not yet reported Eli Lilly and Company 133 participants Est. completion 2011-12 15 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01134224

    A Trial Investigating the Effect of NN5401 in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 39 participants Est. completion 2010-11 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01138488

    A Trial Investigating the Total Exposure of NN5401 (Insulin Degludec/Insulin Aspart) in Children, Adolescents and Adult Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 38 participants Est. completion 2010-11 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01145482

    Mechanisms of Insulin Facilitation of Memory

    Not yet reported University of Texas at Austin 12 participants Est. completion 2014-04 1 site
    Other conditions: Memory Disorders
    View official trial listing →
  • Status unknown NCT NCT01149005

    Cystic Fibrosis (CF) Exacerbation and Insulin Treatment

    Not yet reported Hadassah Medical Organization 30 participants Est. completion 2015-12 1 site
    Prediabetes Other conditions: Cystic Fibrosis, Pulmonary Exacerbation
    View official trial listing →
  • Completed NCT NCT01165684

    Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen

    Not yet reported Novo Nordisk A/S 401 participants Est. completion 2012-04 67 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01173926

    Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 27 participants Est. completion 2010-11 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01174303

    A Trial Investigating the Exposure of NN5401 in Young Adults and Elderly Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 28 participants Est. completion 2010-11 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01194245

    Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus

    Not yet reported Halozyme Therapeutics 135 participants Est. completion 2011-08 19 sites Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01194258

    Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus

    Not yet reported Halozyme Therapeutics 132 participants Est. completion 2011-08 22 sites Stand-alone
    Other conditions: Diabetes Mellitus, Type II
    View official trial listing →
  • Terminated NCT NCT01196104

    Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Inhalation Insulin (TI) Inhalation Powder Using the Gen2 Inhaler

    Not yet reported Mannkind Corporation 39 participants Est. completion 2012-03 29 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01209403

    Insulin-like Growth Factor (IGF-I) in Hemodialysis Patients

    Not yet reported University of Aarhus 12 participants Est. completion 2011-07 1 site
    Other conditions: Kidney Failure, Chronic
    View official trial listing →
  • Completed NCT NCT01211730

    Study of Glycemic Control on Liver Transplantation Outcomes

    Not yet reported Northwestern University 164 participants Est. completion 2016-05 1 site
    Other conditions: Evidence of Liver Transplantation, Hyperglycemia, Rejection
    View official trial listing →
  • Completed NCT NCT01212913

    Comparison of Insulin Glargine/Insulin Glulisine Regimen to Insulin Aspart/Insulin Aspart Protamine 30/70 in Type 2 Diabetes Mellitus Patients (T2DM)

    Not yet reported Sanofi 161 participants Est. completion 2012-05 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01215435

    Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects With Type 2 Diabetes Not Achieving HbA1c Treatment Targets on OADs Alone

    Not yet reported Novo Nordisk A/S 245 participants Est. completion 2012-09 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01223560

    Collection of Information-Rich Type 1 Diabetes Data

    Not yet reported Hvidovre University Hospital 12 participants Est. completion 2010-05 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01240785

    Metformin Versus Insulin in Gestational Diabetes

    Not yet reported Turku University Hospital 221 participants Est. completion 2012-12
    Other conditions: Gestational Diabetes
    View official trial listing →
  • Completed NCT NCT01242826

    Investigation of the Pharmacokinetic Properties of Biphasic Insulin Aspart 50 in Healthy Chinese Subjects

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 2011-03 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01269034

    New Onset Type 1 Diabetes: Role of Exenatide

    Not yet reported Albert Einstein College of Medicine 13 participants Est. completion 2017-01-31 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01269047

    Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia

    Not yet reported Albert Einstein College of Medicine 37 participants Est. completion 2016-12 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01269606

    Comparing Insulin Aspart With Fast-acting Insulin Human in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 13 participants Est. completion 2011-03 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Status unknown NCT NCT01271517

    Basal Analog Study - Comparison of Lantus or Levemir With NPH Insulin From T1DM Diagnosis

    Not yet reported Karolinska Institutet 120 participants 1 site
    Other conditions: Diabetes Mellitus Type 1
    View official trial listing →
  • Completed NCT NCT01272193

    Comparison of NN5401 With Insulin Glargine in Insulin Naive Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 296 participants Est. completion 2011-09 50 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01275131

    Randomized, Double-blind, Crossover, Pharmacokinetic (PK) and Glucodynamic (GD) Study of Continuous Subcutaneous Insulin Infusion (CSII) in Participants With Type 1 Diabetes Mellitus (T1DM)

    Not yet reported Halozyme Therapeutics 45 participants Est. completion 2011-12 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01278160

    Comparison of Biphasic Insulin Aspart 30 Twice Daily With Two Different Initial Dosage Split Regimens in Subjects With Type 2 Diabetes: An Extension to Trial BIASP-3756

    Not yet reported Novo Nordisk A/S 179 participants Est. completion 2011-09 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01283425

    Evaluation of the Safety Use of the InsuPatch Device in Daily Life Conditions

    Not yet reported Insuline Medical Ltd. 147 participants Est. completion 2012-04 8 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01293396

    Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial Lipids

    Not yet reported Medical University of Graz 20 participants Est. completion 2011-03 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01296438

    A Trial Investigating the Pharmacokinetic Properties of NN1218 in Subjects With Diabetes Mellitus, Type 1

    Not yet reported Novo Nordisk A/S 40 participants Est. completion 2011-03 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Terminated NCT NCT01333514

    Carbohydrate Consumption as a Factor in Aspart Dosing

    Not yet reported Rush University Medical Center 14 participants Est. completion 2012-12 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01365507

    Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens

    Not yet reported Novo Nordisk A/S 276 participants Est. completion 2012-04 42 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01388361

    Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin

    Not yet reported Novo Nordisk A/S 413 participants Est. completion 2012-07 124 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01399346

    Investigation of the Impact of Different Application Volumes of Insulin Aspart in Subjects With Type 1 Diabetes

    Not yet reported Medical University of Graz 12 participants Est. completion 2011-06 1 site Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01407289

    A Trial to Investigate Efficacy and Usability of Published Best Practice to Control Glycaemia

    Not yet reported Medical University of Graz 74 participants Est. completion 2012-04 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT01417897

    Human Insulin Analogs: Evaluation of Inflammatory mRNA Expression of Macrophages and Endothelial Function of Short-acting Insulin - HERMES Pilot Study

    Not yet reported ikfe-CRO GmbH 12 participants Est. completion 2012-05 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01427920

    Comparison of Biphasic Insulin Aspart 30 Individually Adjusted by the Subject and the Trial Physician, Both Combined With Metformin in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 348 participants Est. completion 2012-07 41 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01438632

    Pharmacology of Insulin Injected With Jet-injection in Diabetes

    Not yet reported Radboud University Medical Center 24 participants Est. completion 2012-07 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01440140

    Closing the Loop in Adults With Type 1 Diabetes in the Home Setting

    Not yet reported University of Cambridge 24 participants Est. completion 2014-01 3 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01445951

    Clinical Trial Evaluating Technosphere® Insulin Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Over a 24-week Treatment Period

    Not yet reported Mannkind Corporation 518 participants Est. completion 2013-06 90 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01455142

    A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 32 participants Est. completion 2012-01 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01464099

    Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 2008-11 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01467141

    Safety and Efficacy of Insulin Aspart in Children With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 26 participants Est. completion 2003-10-15 6 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01467323

    Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 303 participants Est. completion 1998-09 37 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01467375

    Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 89 participants Est. completion 2004-10-22 12 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01467401

    Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 292 participants Est. completion 2003-05-15 57 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01469143

    A Trial Investigating the Pharmacokinetic Properties of Formulations of NN1218 in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 40 participants Est. completion 2012-01 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01474538

    Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy

    Not yet reported Eli Lilly and Company 122 participants Est. completion 2013-02 12 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01486381

    Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 22 participants Est. completion 2003-05-30 2 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01486862

    Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADs

    Not yet reported Novo Nordisk A/S 26 participants Est. completion 2006-07 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01486914

    Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process

    Not yet reported Novo Nordisk A/S 28 participants Est. completion 2003-02-24 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01486940

    Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 598 participants Est. completion 2002-10 75 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Terminated NCT NCT01486966

    Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 58 participants Est. completion 2012-06 6 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01487369

    Special Survey of Production of Insulin Aspart Specific Antibody

    Novo Nordisk A/S 204 participants Est. completion 2009-10 1 site
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01487382

    Special Survey for Paediatric Subjects

    Novo Nordisk A/S 241 participants Est. completion 2009-10 1 site
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01487408

    Special Survey for Type 1 or Type 2 Diabetic Patients

    Novo Nordisk A/S 1463 participants Est. completion 2009-10 1 site
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01487421

    An Observational Study of Insulin Aspart and, if Necessary, Insulin Levemir (FlexPen®) in the Evening or at Bedtime

    Novo Nordisk A/S 2134 participants Est. completion 2006-10 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01487798

    Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 170 participants Est. completion 2003-11 17 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01487811

    Comparison of Two Biphasic Insulin Aspart 30 Formulations (Current and New Formulation) in Healthy Volunteers

    Not yet reported Novo Nordisk A/S 50 participants Est. completion 2005-11 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01510093

    Diurnal Variation of Exogenous Peptides (Endogenous Insulin Jurgita II)

    Not yet reported Aarhus University Hospital 10 participants Est. completion 2013-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01513473

    A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 350 participants Est. completion 2013-07-30 81 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01513590

    A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 394 participants Est. completion 2012-11-19 49 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01519674

    Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and Metformin

    Not yet reported Novo Nordisk A/S 582 participants Est. completion 2013-10 69 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01520753

    Comparison of Two Biphasic Insulin Aspart Treatments in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 16 participants Est. completion 1999-06 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01520818

    Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes

    Not yet reported Novo Nordisk A/S 666 participants Est. completion 2001-04 77 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01524705

    FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)

    Not yet reported University of Washington 102 participants Est. completion 2014-07 12 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01524809

    Pharmacokinetics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 26 participants Est. completion 2001-06 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01526733

    Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase

    Not yet reported Halozyme Therapeutics 25 participants Est. completion 2013-09 1 site Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01526941

    Comparison of Single Dose and Steady State Pharmacodynamics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 27 participants Est. completion 2001-07 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01526980

    Glycaemic Control of Biphasic Insulin Aspart 70 and 30 in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 31 participants Est. completion 2002-11 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01527539

    Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 25 participants Est. completion 2004-10-12 4 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01527552

    Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Male Subjects

    Not yet reported Novo Nordisk A/S 30 participants Est. completion 2002-12-18 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01527565

    Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Male Subjects

    Not yet reported Novo Nordisk A/S 30 participants Est. completion 2003-02-26 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01527643

    Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Subjects

    Not yet reported Novo Nordisk A/S 30 participants Est. completion 2003-12-17 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01527656

    Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Subjects

    Not yet reported Novo Nordisk A/S 40 participants Est. completion 2004-02 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01530048

    Bioequivalence of Two Insulin Aspart Formulations (100 U/mL Versus 200 U/mL)

    Not yet reported Novo Nordisk A/S 34 participants Est. completion 2006-05 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01531855

    Post-exercise Insulin Reductions in Type 1 Diabetes

    Not yet reported Northumbria University 13 participants Est. completion 2012-08 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01536028

    Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 and Insulin Aspart in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 32 participants Est. completion 2006-07 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01536600

    Observational Study of Biphasic Insulin Aspart 30 Alone or in Combination With Oral Hypoglycaemic Agents in Subjects With Type 2 Diabetes

    Novo Nordisk A/S 33010 participants Est. completion 2006-12 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01536613

    Post Marketing Surveillance Study of Biphasic Insulin Aspart 30

    Novo Nordisk A/S 5346 participants Est. completion 2007-02 1 site
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01536626

    Switch From Premixed Human Insulin to Biphasic Insulin Aspart in the Netherlands

    Novo Nordisk A/S 211 participants Est. completion 2007-04-10 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01536652

    Prandial Orientated Biphasic Insulin Aspart 30 Therapy - the Physiological Premix Insulin Therapy for Type 2 Diabetes

    Novo Nordisk A/S 4994 participants Est. completion 2006-11 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01538511

    Insulin Profile of Biphasic Insulin Aspart 70 to That of Biphasic Insulin Aspart 30 in Healthy Volunteers

    Not yet reported Novo Nordisk A/S 59 participants Est. completion 2007-03-13 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01538576

    Paediatric Subjects - Special Survey

    Novo Nordisk A/S 71 participants Est. completion 2009-10 1 site
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01538589

    Special Survey for Patients With Type 1 or Type 2 Diabetes

    Novo Nordisk A/S 1582 participants Est. completion 2009-10 1 site
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01542060

    Efficacy and Safety of Biphasic Insulin Aspart 30 for the Treatment of Type 2 Diabetes Mellitus

    Novo Nordisk A/S 298 participants Est. completion 2004-12 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01542424

    An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes Mellitus

    Novo Nordisk A/S 1889 participants Est. completion 2006-12 1 site
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01548235

    Observational Safety Study in Subjects With Type 2 Diabetes Mellitus Starting or Switching to Biphasic Insulin Aspart 30 Treatment

    Novo Nordisk A/S 423 participants Est. completion 2007-04 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01548248

    Efficacy and Safety of Levemir® Used as Basal Insulin

    Novo Nordisk A/S 631 participants Est. completion 2006-10 1 site
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01552603

    Artificial Pancreas Control System in an Inpatient Setting

    Not yet reported Legacy Health System 14 participants Est. completion 2013-09 2 sites
    Other conditions: Type I Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01561378

    Cardiac Surgery Neuroprotection Study in Elders

    Not yet reported Albert Einstein College of Medicine 22 participants Est. completion 2014-10 1 site
    Other conditions: Post-operative Cognitive Decline, Post-operative Delirium
    View official trial listing →
  • Completed NCT NCT01565733

    Safety of Treatment Initiation With Biphasic Insulin Aspart 30 in Hospitalised Patients With Type 2 Diabetes

    Novo Nordisk A/S 2223 participants Est. completion 2007-07 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Status unknown NCT NCT01588743

    Effects of Short-term Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes Patients

    Not yet reported Li Guangwei 130 participants
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01589653

    Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients

    Not yet reported Novo Nordisk A/S 155 participants Est. completion 2015-07-09 15 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01620333

    Pharmacokinetics of Biphasic Insulin Aspart 50 and 70 in Japanese Healthy Volunteers

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 2000-04 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01620437

    Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Japanese Subjects

    Not yet reported Novo Nordisk A/S 30 participants Est. completion 2003-12-30 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01620450

    Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process in Healthy Japanese

    Not yet reported Novo Nordisk A/S 34 participants Est. completion 2005-02-26 1 site
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01621776

    Effect of Apidra Compared to Humalog in Decreasing Post-Prandial Hyperglycemia

    Not yet reported University of Florida 107 participants Est. completion 2012-08 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01643382

    Hyperglycemia in Renal Transplantation

    Not yet reported University of California, San Francisco 60 participants Est. completion 2014-08 1 site
    Other conditions: Diabetes, End Stage Renal Disease
    View official trial listing →
  • Terminated NCT NCT01648218

    Insulin Therapy for Post-transplant Glucocorticoid Induced Hyperglycemia

    Not yet reported Vancouver General Hospital 5 participants Est. completion 2013-06 1 site Stand-alone
    Other conditions: Post-Transplant Glucocorticoid Induced Diabetes
    View official trial listing →
  • Completed NCT NCT01649570

    Safety and Efficacy of Insulin Aspart in Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 123 participants Est. completion 2003-08 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01654120

    Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics

    Not yet reported Mountain Diabetes and Endocrine Center 37 participants Est. completion 2013-11 1 site
    Other conditions: Diabetes Mellitus, Type II
    View official trial listing →
  • Completed NCT NCT01678235

    Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus

    Not yet reported Medical University of Warsaw 64 participants Est. completion 2012-09 1 site Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01684943

    Selecting Insulin Analogs for Closed-Loop Control Using Multiplex Pharmacokinetic Profiling

    Not yet reported Massachusetts General Hospital 33 participants Est. completion 2017-12 1 site Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01697618

    Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 13 participants Est. completion 1998-11 2 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01697631

    Glycemic Control of Biphasic Insulin Aspart 30 in Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 131 participants Est. completion 2003-04-24 12 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01697657

    Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir in Well Controlled Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 131 participants Est. completion 2002-11 11 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01698697

    Comparison of Two Insulin Aspart Formulations in Healthy Volunteers

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 2002-10-18 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01702311

    Point-of-Care Glucose Testing and Insulin Supplementation

    Not yet reported Emory University 235 participants Est. completion 2013-12 2 sites
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01704378

    Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen™ in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 89 participants Est. completion 2003-03-14 17 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01707134

    Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 753 participants Est. completion 2000-05 80 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01707160

    Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 in Healthy Volunteers

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 1995-12 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01755416

    Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting

    Not yet reported Albert Einstein College of Medicine 18 participants Est. completion 2015-01 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Terminated NCT NCT01756105

    Efficacy of Metformin in Achieving Glycaemia Goals as Recommended for the Treatment of Gestational Diabetes in Non Obese Women

    Not yet reported University Hospital, Strasbourg, France 84 participants Est. completion 2018-06 5 sites
    Other conditions: Gestational Diabetes, Metformin, Treatment, Oxidative Stress
    View official trial listing →
  • Completed NCT NCT01773798

    A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart 15 in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 33 participants Est. completion 2013-08 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01814137

    A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice Daily

    Not yet reported Novo Nordisk A/S 40 participants Est. completion 2014-03 40 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01819129

    Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 881 participants Est. completion 2015-01-22 144 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01828970

    Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients

    Not yet reported Centre Europeen d'Etude du Diabete 38 participants Est. completion 2012-09 5 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01831765

    Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 1290 participants Est. completion 2015-06-11 191 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01835431

    A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 362 participants Est. completion 2014-11-07 73 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01845831

    Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes

    Not yet reported Emory University 292 participants Est. completion 2016-04 5 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01848990

    CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)

    Not yet reported Halozyme Therapeutics 456 participants Est. completion 2014-09 39 sites Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01850615

    Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 323 participants Est. completion 2014-11-17 58 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01865331

    Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Characteristics of Explorative Formulations of Insulin Degludec and IDegAsp 50 in Healthy Japanese Subjects

    Not yet reported Novo Nordisk A/S 32 participants Est. completion 2007-03 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01868555

    Safety, Pharmacokinetics and Pharmacodynamics of Two IDegAsp (One Explorative) Preparations and Two Insulin Degludec (One Explorative) Preparations in Japanese Subjects

    Not yet reported Novo Nordisk A/S 32 participants Est. completion 2008-02 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01868568

    Comparison of IDegAsp (Inclusive Three Explorative Formulations) With Insulin Degludec and Insulin Aspart Separately Injected in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 55 participants Est. completion 2008-08 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01868581

    Bioequivalence Between Two Explorative Insulin Degludec Formulations and Between Two Explorative IDegAsp Formulations in Healthy Subjects

    Not yet reported Novo Nordisk A/S 58 participants Est. completion 2008-08 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01871870

    Artificial Pancreas Control System in an Outpatient Setting

    Not yet reported Legacy Health System 20 participants Est. completion 2013-10 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01892020

    Investigating Efficacy and Safety of Biphasic Insulin Aspart 50 Twice Daily Versus Biphasic Human Insulin 50 Twice Daily Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 161 participants Est. completion 2014-05 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01905020

    Closed-loop Control of Overnight Glucose Levels in Adults and Adolescents With Type 1 Diabetes

    Not yet reported Institut de Recherches Cliniques de Montreal 28 participants Est. completion 2014-09 3 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01924637

    A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 36 participants Est. completion 2013-11 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01933490

    Post-Gastric Bypass Hypoglycemia

    Not yet reported University of Minnesota 10 participants Est. completion 2014-08 1 site
    Other conditions: Hyperinsulinemic Hypoglycemia
    View official trial listing →
  • Completed NCT NCT01934712

    A Trial Investigating the Pharmacokinetic Properties of FIAsp in Japanese Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 50 participants Est. completion 2014-01-28 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01947556

    Insulin by Jet-injection for Hyperglycemia in Diabetes

    Not yet reported University Medical Center Nijmegen 20 participants Est. completion 2014-11 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01966978

    The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study

    Not yet reported University of Texas Southwestern Medical Center 157 participants Est. completion 2017-12 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Status unknown NCT NCT01974544

    Prevention and Treatment Of Diabetes Complications With Gastric Surgery or Intensive Medicines

    Not yet reported Pontificia Universidad Catolica de Chile 150 participants Est. completion 2016-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01992588

    A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp When Administered as a Bolus in a Continuous Subcutaneous Infusion Regimen in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 48 participants Est. completion 2014-03 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01999322

    A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 37 participants Est. completion 2014-05-14 2 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02003677

    A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Geriatric and Younger Adult Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 67 participants Est. completion 2014-08-14 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02004366

    Linagliptin Inpatient Trial

    Not yet reported Emory University 295 participants Est. completion 2017-03 5 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02006836

    Glycemic Responses to Majia Pomelos in Type 2 Diabetic Patients

    Not yet reported Huazhong University of Science and Technology 59 participants Est. completion 2013-12 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02034513

    A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 501 participants Est. completion 2016-01-11 99 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02035371

    A Trial Investigating the Pharmacokinetic Properties of FIAsp in Children, Adolescents and Adults With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 41 participants Est. completion 2014-07-24 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02036372

    Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus

    Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 150 participants Est. completion 2017-01 3 sites
    Other conditions: Diabetes Mellitus Type II
    View official trial listing →
  • Completed NCT NCT02054429

    Intensive Insulin Therapy With Tight Glycemic Control to Improve Outcomes After Endovascular Therapy for Acute Ischemic Stroke

    Not yet reported University at Buffalo 30 participants Est. completion 2016-12-31 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02059174

    A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-1293 Compared With a Basal Insulin in Participants With Type 1 Diabetes (MK-1293-005)

    Not yet reported Merck Sharp & Dohme LLC 76 participants Est. completion 2015-04-27 Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02089451

    A Trial Comparing the Pharmacokinetic Properties of Faster-acting Insulin Aspart (FIAsp) After Different Injection Regions and Routes of Administration in Healthy Subjects

    Not yet reported Novo Nordisk A/S 21 participants Est. completion 2014-06-06 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT02100475

    A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification

    Not yet reported Novo Nordisk A/S 31 participants Est. completion 2015-04 60 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02101229

    Validation of the Artificial Pancreas Diabeloop Algorithm in the Hospital

    Not yet reported, Not yet reported Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète 17 participants Est. completion 2015-02 3 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02189694

    Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Children With Type 1 Diabetes in a Diabetes Camp

    Not yet reported Institut de Recherches Cliniques de Montreal 33 participants Est. completion 2014-08 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02192450

    Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia

    Not yet reported Nordsjaellands Hospital 149 participants Est. completion 2019-02-28 1 site Stand-alone
    Other conditions: Type 1 Diabetes Mellitus, Nocturnal Hypoglycemia, Recurrent Severe Hypoglycaemia
    View official trial listing →
  • Completed NCT NCT02219750

    Comparison of Premixed Insulin With Basal-plus Insulin in Type 2 Diabetes Patients

    Not yet reported Mackay Memorial Hospital 181 participants Est. completion 2016-08 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Withdrawn NCT NCT02222623

    The Inova Type 2 Diabetes Mellitus Study

    Not yet reported Inova Health Care Services Est. completion 2016-05 1 site
    Other conditions: Diabetes, Type 2
    View official trial listing →
  • Completed NCT NCT02230618

    Post Marketing Surveillance (PMS) Study of Ryzodeg™ (Insulin Degludec/Insulin Aspart) in Patients With Diabetes Mellitus in Routine Clinical Practice in India

    Novo Nordisk A/S 1029 participants Est. completion 2017-06-01 35 sites
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02272296

    Reliability of Insulin by Jet Injection

    Not yet reported Radboud University Medical Center 30 participants Est. completion 2015-08 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02276859

    Normal Versus Dual Wave Insulin Bolus for High-protein Food

    Not yet reported Medical University of Warsaw 70 participants Est. completion 2015-09 1 site Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02328040

    Randomized Trial Comparing Sitagliptin to Placebo in Closed Loop

    Not yet reported Albert Einstein College of Medicine 17 participants Est. completion 2016-01 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02359617

    Continuous Glucose Sensing at the Site of Subcutaneous Insulin Administration

    Not yet reported Medical University of Graz 10 participants Est. completion 2015-03 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02408120

    Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 Diabetes

    Not yet reported Emory University 226 participants Est. completion 2019-12-11 2 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02416765

    Closed-loop Control of Postprandial Glucose Levels in Adults With Type 1 Diabetes

    Not yet reported Institut de Recherches Cliniques de Montreal 15 participants Est. completion 2015-10 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02417090

    Late Metabolic Effects of Metformin Therapy in Gestational Diabetes

    Turku University Hospital 173 participants Est. completion 2019-12-01
    Other conditions: Gestational Diabetes
    View official trial listing →
  • Completed NCT NCT02419859

    A Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus

    Not yet reported CeQur Corporation 20 participants Est. completion 2015-11 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02420262

    A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 506 participants Est. completion 2016-10-05 117 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02443402

    Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery

    Not yet reported Emory University 68 participants Est. completion 2016-12 4 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02449603

    Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes

    Not yet reported Xijing Hospital 150 participants Est. completion 2018-04 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02453685

    A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic Patients

    Not yet reported Novo Nordisk A/S 335 participants Est. completion 2016-09-20 41 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Withdrawn NCT NCT02488616

    Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 Diabetes

    Not yet reported Institut de Recherches Cliniques de Montreal Est. completion 2018-11 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Withdrawn NCT NCT02490098

    Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes

    Not yet reported Institut de Recherches Cliniques de Montreal Est. completion 2018-07 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02491528

    A Phase III Study of Insulin Aspart Injection to Evaluate the Efficacy and Safety

    Not yet reported Tonghua Dongbao Pharmaceutical Co.,Ltd 563 participants Est. completion 2016-08-12 2 sites Stand-alone
    Other conditions: Diabetes
    View official trial listing →
  • Terminated NCT NCT02496780

    The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic Cystic Fibrosis Patients

    Not yet reported, Not yet reported University of Minnesota 65 participants Est. completion 2022-07 2 sites
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT02500706

    Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 1108 participants Est. completion 2017-08-16 152 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02509429

    Comparison of an Artificial Pancreas Versus Threshold Low Glucose Suspend in Type 1 Diabetic Children

    Not yet reported University Hospital, Montpellier 24 participants Est. completion 2016-12 4 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Withdrawn NCT NCT02518022

    How to be Safe With Alcoholic Drinks in Diabetes

    Not yet reported Kinderkrankenhaus auf der Bult Est. completion 2016-06 1 site
    Other conditions: Type 1 Diabetes Mellitus, Hypoglycemia
    View official trial listing →
  • Completed NCT NCT02518945

    Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes

    Not yet reported University at Buffalo 26 participants Est. completion 2016-04 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02556840

    Impact on Birth Weight of Two Therapeutic Strategies (Insulin Therapy From the Beginning of Pregnancy vs. Insulin Therapy Initiated According to Fetal Growth Evaluated by Ultrasonography Measurements) in Pregnant Women With Monogenic Diabetes

    Not yet reported Assistance Publique - Hôpitaux de Paris 46 participants Est. completion 2020-12-09 1 site
    Other conditions: Maturity-Onset Diabetes of the Young
    View official trial listing →
  • Completed NCT NCT02556918

    Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery

    Not yet reported Emory University 202 participants Est. completion 2018-11-06 3 sites Stand-alone
    Other conditions: Hyperglycemia
    View official trial listing →
  • Completed NCT NCT02582242

    Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin

    Not yet reported Novo Nordisk A/S 437 participants Est. completion 2017-04-18 50 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Status unknown NCT NCT02590016

    Glucose Control During Labour in Gestational Diabetes Mellitus With Insulin Treatment: A Randomized Controlled Trial

    Not yet reported Tampere University Hospital 50 participants Est. completion 2021-11 1 site Stand-alone
    Other conditions: Gestational Diabetes, Hypoglycemia, Neonatal
    View official trial listing →
  • Completed NCT NCT02612844

    A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0143-0406 A 0.6 mmol/L in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 48 participants Est. completion 2016-06 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02621489

    Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects

    Not yet reported Karolinska Institutet 38 participants Est. completion 2022-10 1 site
    Other conditions: Atherosclerosis, Diabetes, Restenosis
    View official trial listing →
  • Completed NCT NCT02626936

    Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation

    Not yet reported Institut de Recherches Cliniques de Montreal 10 participants Est. completion 2016-06 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02648217

    Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily and Biphasic Insulin Aspart Twice Daily in Subjects With Type 2 Diabetes Mellitus Before, During and After Ramadan

    Not yet reported Novo Nordisk A/S 263 participants Est. completion 2016-09-05 32 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02670915

    Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 834 participants Est. completion 2018-03-03 155 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Terminated NCT NCT02680054

    Additional Insulin for Fat and Protein in Children With Diabetes Study

    Not yet reported Oxford University Hospitals NHS Trust 38 participants Est. completion 2018-08-31 2 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT02685449

    Insulin Requirement for Pure-protein Meal in Children With Type 1 Diabetes on Insulin Pumps.

    Not yet reported Medical University of Warsaw 70 participants Est. completion 2018-08 1 site
    Other conditions: Diabetes type1
    View official trial listing →
  • Completed NCT NCT02688933

    A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus

    Not yet reported Sanofi 638 participants Est. completion 2017-06-19 100 sites Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02741687

    Sitagliptin in Non-Diabetic Patients Undergoing General Surgery

    Not yet reported Emory University 80 participants Est. completion 2017-04 2 sites Stand-alone
    Other conditions: Hyperglycemia
    View official trial listing →
  • Completed NCT NCT02762578

    Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 543 participants Est. completion 2017-06-19 42 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02798250

    Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation - Part 2

    Not yet reported Institut de Recherches Cliniques de Montreal 11 participants Est. completion 2017-03 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Withdrawn NCT NCT02811484

    Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes

    Not yet reported Weill Medical College of Cornell University Est. completion 2018-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02821052

    Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ryzodeg®

    Novo Nordisk A/S 1355 participants Est. completion 2018-11-24 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02824510

    Evaluation of Glycemic Changes During Exercise in Children With Type 1 Diabetes

    Not yet reported Cliniques universitaires Saint-Luc- Université Catholique de Louvain 24 participants Est. completion 2017-01 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02825251

    Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 472 participants Est. completion 2017-07-21 92 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02844790

    A Trial Investigating the Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart in Healthy Chinese Subjects

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 2016-09-27 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02855307

    Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes

    Not yet reported Institut de Recherches Cliniques de Montreal 37 participants Est. completion 2018-12 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT02871089

    Closed Loop From Onset in Type 1 Diabetes

    Not yet reported University of Cambridge 96 participants Est. completion 2024-07-31 7 sites Stand-alone
    Other conditions: Diabetes Mellitus, Type 1 Diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT02879409

    HbA1c Variability in Type II Diabetes

    Not yet reported Weill Cornell Medical College in Qatar 150 participants Est. completion 2026-10-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02906917

    A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification

    Not yet reported Novo Nordisk A/S 532 participants Est. completion 2017-12-24 71 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02910518

    A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus

    Not yet reported Sanofi 44 participants Est. completion 2017-05-03 1 site Stand-alone
    Other conditions: Type1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02933645

    Effects of Intranasal Insulin Administration on Tissue Specific Insulin Sensitivity

    Not yet reported Turku University Hospital 10 participants Est. completion 2016-12 1 site
    Other conditions: Insulin Resistance
    View official trial listing →
  • Completed NCT NCT02933853

    A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 2 Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 61 participants Est. completion 2017-12-21 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Status unknown NCT NCT03018665

    A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese

    Not yet reported The First Hospital of Jilin University 200 participants 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03101865

    The Artificial Pancreas in Very Young Children With T1D - Pilot (KidsAP01)

    Not yet reported University of Cambridge 24 participants Est. completion 2018-05-11 7 sites Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT03112538

    Improving Glycaemic Control in Malaysian Patients With Type 2 Diabetes Mellitus With Insulin Pump Therapy

    Not yet reported Clinical Research Centre, Malaysia 118 participants Est. completion 2018-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03143816

    Study Comparing Prandial Insulin Aspart vs. Technosphere Insulin in Patients With Type 1 Diabetes on Multiple Daily Injections: Investigator-Initiated A Real-life Pilot Study-STAT Study

    Not yet reported University of Colorado, Denver 60 participants Est. completion 2018-01-31 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03179280

    Effect of Dual-wave Insulin Bolus on Postprandial Glycaemia

    Not yet reported Aristotle University Of Thessaloniki 10 participants Est. completion 2011-05 1 site
    Other conditions: Type1 Diabetes
    View official trial listing →
  • Completed NCT NCT03179332

    A Trial to Evaluate the Pharmacokinetic and Pharmacodynamic Properties of BioChaperone® Insulin Lispro, Fiasp® and NovoRapid® Delivered by an Insulin Pump

    Not yet reported Adocia 43 participants Est. completion 2017-09-27 1 site
    Other conditions: Type1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03202875

    A Study to Compare Pharmacokinetics (PK) and Pharmacodynamics (PD) of SAR341402 to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus

    Not yet reported Sanofi 30 participants Est. completion 2012-12-28 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT03211858

    Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin Glargine

    Not yet reported Sanofi 597 participants Est. completion 2019-01-12 82 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03212950

    Closed-Loop With Faster Aspart in Young Adults With Type 1 Diabetes

    Not yet reported University of Ljubljana, Faculty of Medicine 20 participants Est. completion 2017-11-01 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT03220919

    Efficacy and Safety of Weight-Based Insulin Titration Regimen in Hospitalized Patients With Type 2 Diabetes

    Not yet reported Second Affiliated Hospital of Guangzhou Medical University 500 participants Est. completion 2019-02 1 site
    Other conditions: Efficacy, Self, Adverse Effect
    View official trial listing →
  • Completed NCT NCT03226210

    Comparison of Efficacy and Safety of Prandilin and NovoRapid in Newly Diagnosed Type 2 Diabetes

    Not yet reported Nanjing First Hospital, Nanjing Medical University 110 participants Est. completion 2016-07-01 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT03244241

    Basal-bolus Insulin Therapy Versus Standard Therapy for the Inpatient Management of Type 2 Diabetes: the IDA2 Study

    Not yet reported Merete Bechmann Christensen 100 participants Est. completion 2018-04-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT03260868

    Evaluation of Virtual Versus Traditional Study Conducted in a Group Pilot Study in Adult Patients With Type 1 Diabetes Mellitus (eStudy)

    Not yet reported Sanofi 15 participants Est. completion 2018-11-22 6 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03268005

    Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 1264 participants Est. completion 2019-01-29 167 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT03328845

    Impact on the Oxidative Stress of the Different Analogues of Insulin in People With Type 1 Diabetes. (Ineox Study)

    Not yet reported Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 300 participants Est. completion 2021-11-20 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03336528

    Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 Diabetes

    Not yet reported Emory University 180 participants Est. completion 2021-03-01 4 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03359837

    Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy

    Not yet reported Sanofi 384 participants Est. completion 2020-06-29 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03374774

    A Non-interventional Study of Ability and Willingness to Pay for BIAsp 30 in a Real World Population With Type 2 Diabetes Mellitus (T2DM)

    Novo Nordisk A/S 516 participants Est. completion 2018-07-04 18 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT03377699

    Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 225 participants Est. completion 2020-12-17 71 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03407599

    A Trial Comparing the Pharmacokinetic Properties of Fast-acting Insulin Aspart Between Children, Adolescents and Adults With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 46 participants Est. completion 2018-07-05 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03416855

    A Regulatory Post Marketing Surveillance (rPMS) Study of Ryzodeg® FlexTouch® (Insulin Degludec /Insulin Aspart) to Evaluate Safety and Effectiveness in Patients With Diabetes Mellitus in Routine Clinical Practice in Korea

    Novo Nordisk A/S 768 participants Est. completion 2020-05-19 27 sites
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03430856

    Comparison of Insulin Tregopil (IN-105) With Insulin Aspart in Type 2 Diabetes Mellitus Patients

    Not yet reported, Not yet reported Biocon Limited 143 participants Est. completion 2019-02-20 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03436498

    Safety Assessment of SAR341402 and NovoLog® Used in Continuous Subcutaneous Insulin Infusion for Type 1 Diabetes Mellitus Patients

    Not yet reported Sanofi 45 participants Est. completion 2018-10-06 3 sites Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03449433

    A Meal Test Study of LY900014 in Participants With Type 1 Diabetes Mellitus

    Not yet reported Eli Lilly and Company 80 participants Est. completion 2018-08-14 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03450863

    Study on How Fiasp® Can Influence Blood Sugar Levels of type1 Diabetic Patients in Their Daily Lives, With the Help of the Freestyle Libre® Device

    Novo Nordisk A/S 320 participants Est. completion 2019-09-04 1 site
    Other conditions: Diabetes, Diabetes Mellitus, Type 1 Diabetes
    View official trial listing →
  • Terminated NCT NCT03511521

    Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia

    Not yet reported Northwestern University 3 participants Est. completion 2019-08-15 1 site Stand-alone
    Other conditions: Hyperglycemia Steroid-induced, Insulin Resistance, Diabetes
    View official trial listing →
  • Completed NCT NCT03579615

    Comparison of Day and Night Closed-loop With Faster-acting Insulin Aspart With Insulin Aspart

    Not yet reported Manchester University NHS Foundation Trust 18 participants Est. completion 2022-08-01 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03659799

    Comparison of FiAsp and Aspart During Postprandial Exercise in Adults With Type 1 Diabetes

    Not yet reported Institut de Recherches Cliniques de Montreal 40 participants Est. completion 2023-03-30 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT03660553

    Simplified Insulin Regimen for the Elderly

    Not yet reported University of Miami 7 participants Est. completion 2022-06-30 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03689374

    A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 2274 participants Est. completion 2021-02-22 210 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03723759

    A Research Study Looking at How Faster Aspart Injected in Double Concentration Works in the Body of People With Type 1 Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 56 participants Est. completion 2019-03-27 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03737240

    IDegLira HIGH Trial

    Not yet reported Emory University 145 participants Est. completion 2022-07-08 2 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03745157

    RESILIENT: A Research Study, Looking at How Ryzodeg® Works in People With Type 2 Diabetes in Local Clinical Practice in Japan

    Novo Nordisk A/S 246 participants Est. completion 2019-10-29 29 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03760068

    Mylan Insulin Aspart Study

    Not yet reported Mylan Inc. 478 participants Est. completion 2020-01-17 158 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03770767

    Insulin Fiasp vs. Insulin Novorapid During Pregnancy and Laction in Women With Pre-existing Diabetes

    Not yet reported Rigshospitalet, Denmark 216 participants Est. completion 2023-03-23 1 site
    Other conditions: Diabetes Mellitus, Pregnancy Complications
    View official trial listing →
  • Completed NCT NCT03800875

    Insulin-plus-pramlintide Closed-loop Strategy to Regulate Glucose Levels Without Carbohydrate Counting

    Not yet reported McGill University 24 participants Est. completion 2020-09-19 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03816761

    Research Study to Look at Fast-acting Insulin Aspart With the Insulin Pump System 'iLet™' in Adults With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 2019-06-10 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03824002

    Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables

    Not yet reported University of Palermo 92 participants Est. completion 2018-04-20 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Withdrawn NCT NCT03862690

    A Research Study, Looking at How NovoMix® Works in People With Type 2 Diabetes in Local Clinical Practice in Algeria

    Novo Nordisk A/S Est. completion 2021-06-28 2 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03874715

    Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine

    Not yet reported Sanofi 210 participants Est. completion 2020-07-08 33 sites Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03895515

    Effect of Fiasp® in Type 1 Diabetes Treatment

    Novo Nordisk A/S 178 participants Est. completion 2020-12-21 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03916601

    Comparison of Exposure and Activity of SAR341402 Mix 70/30 to NovoLog Mix 70/30, NovoMix 30 and SAR341402 Rapid-acting Solution in Patients With Type 1 Diabetes Mellitus

    Not yet reported Sanofi 52 participants Est. completion 2018-03-22 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT03959514

    AT247, NovoRapid® and Fiasp® in Glucose Clamp Study

    Not yet reported Arecor Limited 18 participants Est. completion 2019-08-08 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03977727

    FIasp® vs. Novolog® in Type 1 Diabetics Using 670G Medtronic Pump

    Not yet reported Texas Diabetes & Endocrinology, P.A. 40 participants Est. completion 2020-04-20 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03981627

    A Trial to Assess Safety and Efficacy of ADO09 Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus

    Not yet reported, Not yet reported Adocia 44 participants Est. completion 2020-06-27 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03987191

    Insulin Pump to Multiple Daily Injection Transition Clinical Trial

    Not yet reported University of Colorado, Denver 38 participants Est. completion 2020-10-08 1 site Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT03993366

    Pramlintide and Fiasp Closed-Loop With a Simple Meal Announcement

    Not yet reported McGill University 8 participants Est. completion 2019-08-06 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT04019821

    Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index Meal

    Not yet reported Medical University of Warsaw 72 participants Est. completion 2023-04-01 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT04031599

    Assessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose Levels

    Not yet reported Institut de Recherches Cliniques de Montreal 30 participants Est. completion 2021-12-14 2 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT04042441

    A Research Study, Looking at How Ryzodeg® (Insulin Degludec/Insulin Aspart) Works in People With Type 2 Diabetes in Local Clinical Practice

    Novo Nordisk A/S 1122 participants Est. completion 2020-12-11 64 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04053712

    Dual-hormone Closed-loop Glucose Control in Type 1 Diabetes

    Not yet reported Steno Diabetes Center Copenhagen 13 participants Est. completion 2021-03-19 1 site
    Other conditions: Type 1 Diabetes, Hypoglycemia
    View official trial listing →
  • Completed NCT NCT04055480

    Closing the Loop in Adults With Type 1 Diabetes Under Free Living Conditions

    Not yet reported University of Cambridge 25 participants Est. completion 2020-08-30 4 sites Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT04079413

    Efficacy and Safety of GP40071 Compared to NovoRapid® Penfill® in Type 1 Diabetes Mellitus Patients

    Not yet reported Geropharm 264 participants Est. completion 2020-01-21 14 sites
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT04112069

    The Insulin-Only Bionic Pancreas Bridging Study- Pediatric Transitional Study

    Not yet reported Massachusetts General Hospital 20 participants Est. completion 2018-11-19 3 sites
    Other conditions: Type1 Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT04120623

    Therapeutic Effect of Dapagliflozin Combined With CSII on Newly Diagnosed Type 2 Diabetes Mellitus

    Not yet reported Nanjing First Hospital, Nanjing Medical University 100 participants Est. completion 2020-02-28 Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04149262

    Fiasp® Versus NovoRapid® in Children With Type 1 Diabetes on MiniMed 640G Pump With Sensor

    Aristotle University Of Thessaloniki 44 participants Est. completion 2023-02-15 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT04157738

    A Study of Rapid-Acting Mealtime Insulin in Children and Adolescents With Newly Diagnosed Type 1 Diabetes Mellitus

    Not yet reported Emory University 24 participants Est. completion 2020-12-17 1 site
    Other conditions: Diabetes Mellitus, Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT04184466

    A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Aspart to NovoRapid® Penfill® in Healthy Subjects

    Not yet reported Geropharm 26 participants Est. completion 2018-12-19 2 sites Stand-alone
    Other conditions: Clamp Study
    View official trial listing →
  • Completed NCT NCT04184492

    A Study to Compare Pharmacokinetics and Pharmacodynamics of GP-40081 to NovoMix® 30 Penfill® in Healthy Subjects

    Not yet reported Geropharm 34 participants Est. completion 2019-06-28 2 sites Stand-alone
    Other conditions: Clamp Study
    View official trial listing →
  • Completed NCT NCT04196231

    Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)

    Not yet reported University of Campania Luigi Vanvitelli 258 participants Est. completion 2020-10-20 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04200313

    The Insulin-Only Bionic Pancreas Pivotal Trial

    Not yet reported Jaeb Center for Health Research 440 participants Est. completion 2022-01-14 16 sites
    Other conditions: Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Status unknown NCT NCT04226105

    Efficacy and Safety of GP40081 Сompared to NovoMix® 30 FlexPen® in Type 2 Diabetes Mellitus Patients

    Not yet reported Geropharm 264 participants Est. completion 2020-12-25 14 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT04233203

    Faster Aspart on Insulin-pump Treated T1DM Patients

    Jesús Moreno Fernández 48 participants Est. completion 2020-12-31 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT04237129

    PK/PD Study of Gan & Lee Insulin Aspart Injection vs. US & EU NovoLog®/NovoRapid® in Healthy Males

    Not yet reported Gan and Lee Pharmaceuticals, USA 36 participants Est. completion 2019-12-16 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Status unknown NCT NCT04243629

    Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes

    Not yet reported McGill University 26 participants Est. completion 2024-04 1 site
    Other conditions: Diabetes Mellitus, Type 1, Type 1 Diabetes, Postprandial Hyperglycemia
    View official trial listing →
  • Completed NCT NCT04292535

    Safety and Efficacy of Combining Intranasal Insulin & Acute Exercise

    Not yet reported Michigan State University 116 participants Est. completion 2020-02-20 1 site Stand-alone
    Other conditions: Insulin, Exercise
    View official trial listing →
  • Terminated NCT NCT04381429

    Effect of Postprandial Insulin Administration of Faster-acting Insulin Analogue Versus Pre-prandial Administration of Acting-insulin Analogue in Cystic Fibrosis Related Diabetes

    Not yet reported University Hospital, Strasbourg, France 38 participants Est. completion 2025-01-20 1 site
    Other conditions: Cystic Fibrosis-related Diabetes
    View official trial listing →
  • Completed NCT NCT04409587

    Basal Insulin Glycemic ControL With DEglugec vs Aspart Via Pump

    Not yet reported Mountain Diabetes and Endocrine Center 59 participants Est. completion 2020-11-01 1 site
    Other conditions: Type1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT04460326

    Novolog vs. Fiasp Insulin in Non-critically Ill Hospitalized Patients With Type 2 Diabetes Mellitus

    Not yet reported Boston Medical Center 137 participants Est. completion 2023-05-27 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04538352

    Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2D

    Not yet reported The Cleveland Clinic 60 participants Est. completion 2023-11-01 1 site Mixed
    Type 2 diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT04542148

    Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes

    Not yet reported University of Alabama at Birmingham 120 participants Est. completion 2026-12-31 4 sites
    Type 2 diabetes Other conditions: Preterm Birth, Pregnancy, High Risk, Diabetes, Gestational
    View official trial listing →
  • Completed NCT NCT04588259

    Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With Diabetes

    Not yet reported Novo Nordisk A/S 331 participants Est. completion 2022-08-05 40 sites
    Type 2 diabetes Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Status unknown NCT NCT04620967

    Fast-Acting Insulin Aspart and Insulin Pump Settings

    Not yet reported Kirsten Nørgaard 40 participants Est. completion 2022-06-30 1 site Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT04655690

    A Study to Look at How Safe Insulin NNC0471-0119 is and How it Works in People With Type 1 Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 48 participants Est. completion 2021-11-26 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT04656106

    A Study Investigating the Clinical Parameters Associated With the Use of Ryzodeg® (Insulin Degludec/Insulin Aspart) in a Real-world Adult Population With Type 2 Diabetes in South Korea

    Novo Nordisk A/S 200 participants Est. completion 2021-07-01 6 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04660305

    AT278 and NovoRapid® in Glucose Clamp Study

    Not yet reported Arecor Limited 38 participants Est. completion 2021-06-11 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT04711382

    The Use of Faster Acting Aspart in Type 1 Diabetes Patients

    University Hospital, Antwerp 438 participants Est. completion 2021-01-01 1 site
    Other conditions: Type 1 Diabetes, Insulin, Time in Range
    View official trial listing →
  • Completed NCT NCT04726657

    Comparison of Two Biphasic Insulin Regimens

    Not yet reported Aristotle University Of Thessaloniki 36 participants Est. completion 2020-02-03
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04739241

    Premixed vs Basal Bolus Insulin Therapy in Older Patients With Type 2 Diabetes

    Not yet reported Consorci Sanitari Integral 60 participants Est. completion 2018-06-19 Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04759144

    FASter Insulin in Closed-loop Technology in Children

    Not yet reported University of Cambridge 27 participants Est. completion 2022-12-01 2 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT04772729

    Does the Use of Fiasp vs. Asp Lead to the Prolonged TIR in Children With Type 1 Diabetes?

    Not yet reported Medical University of Warsaw 77 participants Est. completion 2024-03-01
    Other conditions: Diabetes type1, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT04834362

    Insulin for Hyperglycemia in Stroke Trial

    Not yet reported National Institute of Neurosciences and Hospital, Dhaka 452 participants Est. completion 2021-06-25 1 site Stand-alone
    Cardiovascular disease Other conditions: Hyperglycemia
    View official trial listing →
  • Completed NCT NCT04848480

    A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6)

    Not yet reported Novo Nordisk A/S 582 participants Est. completion 2022-12-02 130 sites Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT04853030

    Fast Advanced Closed-Loop Therapy

    Not yet reported University of Ljubljana, Faculty of Medicine 30 participants Est. completion 2021-09-20 2 sites Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT04880850

    A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)

    Not yet reported Novo Nordisk A/S 582 participants Est. completion 2022-06-16 116 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04949867

    Dual-Hormone Closed-Loop Glucose Control in Adolescents With Type 1 Diabetes

    Not yet reported Steno Diabetes Center Copenhagen 11 participants Est. completion 2022-04-26 2 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT04965051

    Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 40 participants Est. completion 2023-12 1 site Stand-alone
    Other conditions: Type 1 Diabetes Mellitus With Diabetic Gastroparesis, HbA1c, Time in Range
    View official trial listing →
  • Completed NCT NCT04974528

    Afrezza® INHALE-1 Study in Pediatrics

    Not yet reported Mannkind Corporation 319 participants Est. completion 2025-04-29 39 sites
    Type 2 diabetes Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT05013229

    A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)

    Not yet reported Novo Nordisk A/S 679 participants Est. completion 2023-11-14 182 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05069545

    A Research Study Looking at How the Use of NovoPen® 6 for Treatment With Tresiba® & Fiasp® Affects the Blood Sugar Level in Patients With Type 1 Diabetes as Part of Local Clinical Practice

    Novo Nordisk A/S 411 participants Est. completion 2024-09-10 26 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Status unknown NCT NCT05104424

    The Study of Quadruple Therapy Intranasal Insulin, Zinc, Gabapentin, Ice Cube Stimulation for Post COVID-19 Smell and Taste Dysfunctions

    Not yet reported Ministry of Health, Saudi Arabia 22 participants Est. completion 2022-10-01
    Other conditions: Smell Dysfunction, Taste Disorders, Taste Disorder, Secondary, Sweet, Taste Disorder, Secondary, Bitter, Smell Disorder
    View official trial listing →
  • Completed NCT NCT05184868

    AT247, NovoLog® and Fiasp® Administered Via Continuous Subcutaneous Infusion in Glucose Clamp Study

    Not yet reported Arecor Limited 24 participants Est. completion 2022-09-09 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT05199714

    A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 Diabetes

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 12 participants Est. completion 2023-03-25 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT05218915

    Basal Plus GLP1-ra on Glycemic Variability in CKD

    Not yet reported Elaine Chow 95 participants Est. completion 2024-10-30 1 site
    Chronic kidney disease Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT05221580

    China Research of IDEgAsp Treatment in Real-world Clinical practicE (CREATE)

    Novo Nordisk A/S 887 participants Est. completion 2023-03-31 50 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05224258

    Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

    Not yet reported Medtronic MiniMed, Inc. 240 participants Est. completion 2024-06-21 18 sites Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT05262595

    A Study to Look at How Insulin NNC0471-0119 Works in the Body in People With Type 1 Diabetes When Injected by Insulin Pump

    Not yet reported Novo Nordisk A/S 19 participants Est. completion 2022-09-05 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT05284344

    The Impact of Glucotoxicity on Gastric Emptying in Chinese Patients With Newly Diagnosed Type 2 Diabetes

    University of Adelaide 78 participants Est. completion 2023-12-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05360537

    Effects of Degludec/Liraglutide on Time in Range, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic Inpatients

    Not yet reported University of Palermo 100 participants Est. completion 2022-04-20 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05413369

    iGlarLixi vs IDegAsp in Chinese Participants After OAD(s)

    Not yet reported Sanofi 582 participants Est. completion 2023-10-20 60 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05417841

    Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T2DM

    Not yet reported Beijing Hospital 218 participants Est. completion 2025-08-15 7 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05539872

    Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-Acting Insulin Aspart (I004) and NovoLog After Single-Dose Subcutaneous Administration to Healthy Volunteers

    Not yet reported, Not yet reported Amphastar Pharmaceuticals, Inc. 69 participants Est. completion 2023-01-30 1 site Stand-alone
    Other conditions: Pharmacokinetics, Pharmacodynamics
    View official trial listing →
  • Status unknown NCT NCT05641337

    Research on Optimal Strategy of Hypoglycemic Therapy for Cirrhosis With Diabetes

    Not yet reported Huashan Hospital 184 participants Est. completion 2025-12-30 1 site Stand-alone
    Other conditions: Liver Cirrhosis, Diabetes
    View official trial listing →
  • Completed NCT NCT05653050

    Closing the Loop in People with Type 1 Diabetes

    Not yet reported University of Cambridge 26 participants Est. completion 2024-10-15 4 sites Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT05719961

    Bioequivalence Study of INS062 and Pharmacokinetics and Pharmacokinetics Study of Single Injection of HR20014 in Healthy Subjects

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 60 participants Est. completion 2023-07-30 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT05737576

    The Pharmacokinetics and Pharmacodynamics Between HR011408 and NovoRapid® in Healthy Subject

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 61 participants Est. completion 2023-12-08 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT05754424

    AT278, NovoRapid® and Humulin® R (U500) in Glucose Clamp Study

    Not yet reported Arecor Limited 41 participants Est. completion 2024-02-12 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT05767255

    Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP-1 Analogue

    Not yet reported Hospital Universitario San Ignacio 66 participants Est. completion 2023-08-30 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05799781

    Two Way Crossover Closed Loop MPC vs Control IQ

    Not yet reported Oregon Health and Science University 29 participants Est. completion 2025-01-28 2 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT05802862

    A Study of Insulin Degludec/Insulin Aspart Biosimilar (22011) Compared With Insulin Degludec/Insulin Aspart(Ryzodeg) in Participants With Type 2 Diabetes in China

    Not yet reported Sunshine Lake Pharma Co., Ltd. 414 participants Est. completion 2024-08-16 1 site Stand-alone
    Other conditions: Diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT05946798

    Role of NADPH Oxidase in Microvascular Dysfunction Following GDM

    Not yet reported Anna Stanhewicz, PhD 40 participants Est. completion 2028-06-01 1 site Stand-alone
    Other conditions: Gestational Diabetes, Oxidative Stress, Vascular Endothelial Function
    View official trial listing →
  • Completed NCT NCT06199505

    A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Naïve or Insulin Treated Subjects with T2DM

    Not yet reported Gan and Lee Pharmaceuticals, USA 153 participants Est. completion 2024-07-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT06375031

    Comparison of HR011408 and NovoRapid® in Subjects With Diabetics

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 30 participants Est. completion 2024-07-15 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT06492226

    Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS(A), US-NovoLog®, and EU-NovoRapid®

    Not yet reported Xentria, Inc. 54 participants Est. completion 2024-10-31 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Status unknown NCT NCT06558708

    A Trial Comparing Efficacy, Tolerability, and Safety of GZR101 Injection Once Daily (OD) and GZR33-70 Injection OD

    Not yet reported Gan and Lee Pharmaceuticals, USA 60 participants Est. completion 2024-12 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT06607224

    Effect of the Use of Continuous Glucose Monitoring Versus Standard Glycemic Control in Hospitalized Patients with Type 2 Diabetes.

    Not yet reported Hospital General Universitario Gregorio Marañon 40 participants Est. completion 2024-01-30 1 site Stand-alone
    Type 2 diabetes Other conditions: Hospitalization
    View official trial listing →
  • Completed NCT NCT06809621

    A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 1 Diabetes When Given by an Insulin Pump

    Not yet reported Novo Nordisk A/S 43 participants Est. completion 2025-07-28 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT06948760

    Testing a Conversion Factor for a More Rapidly Acting Insulin in an Automated Insulin Delivery System Among Adolescents With T1D

    Not yet reported Mark D. DeBoer, MD, MSc., MCR 11 participants Est. completion 2026-03-10 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT07076199

    A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 877 participants Est. completion 2027-03-01 182 sites Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Not yet recruiting NCT NCT07173712

    Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes

    Not yet reported Yanbing Li 324 participants Est. completion 2027-12-31
    Type 2 diabetes
    View official trial listing →
  • Not yet recruiting NCT NCT07387003

    Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 Diabetes

    Not yet reported Gan & Lee Pharmaceuticals. 345 participants Est. completion 2027-09-23 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT07600944

    Comparison of the Pharmacokinetics （PK）and Pharmacodynamics （PD）Biosimilarity of Insulin Aspart Injections After Single-Dose Subcutaneous Administration to Healthy Volunteers

    Not yet reported Zhuhai United Laboratories Co., Ltd. 44 participants Est. completion 2026-07-03 1 site Stand-alone
    Other conditions: Pharmacokinetics and Pharmacodynamics
    View official trial listing →
  • Not yet recruiting NCT NCT07645079

    Automated Insulin Delivery Versus Daily Injections for Hospital Diabetes Care

    Not yet reported Steno Diabetes Center Copenhagen 92 participants Est. completion 2027-07-30 2 sites Stand-alone
    Type 2 diabetes Other conditions: Infection, CGM
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Insulin Aspart, .Insulin Aspart Protamine and Insulin Aspart, Insulin Aspart Protamine and Insulin Aspart Mix 70/30

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.